Dicloxacillin Sodium

CHEMBL1200701 Phase 4 Disetujui Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

492.3 g/mol

LogP

—

Phase

4

The sodium salt form of dicloxacillin, a beta-lactamase-stable penicillin antibiotic used for skin infections and other conditions caused by beta-lactamase-producing staphylococci. It is taken by mouth and well tolerated.

Berat Molekul

492,3000 g/mol

TPSA

141,00 Å²

Area Terapeutik

Atopic Dermatitis

Mekanisme Kerja

Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), preventing transpeptidation and cross-linking of peptidoglycan chains. This weakens the bacterial cell wall, leading to osmotic lysis and cell death.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanisme

Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), preventing transpeptidation and cross-linking of peptidoglycan chains. This weakens the bacterial cell wall, leading to osmotic lysis and cell …

Struktur 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

Cc1onc(-c2c(Cl)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)[O-].O.[Na+]

InChI

InChI=1S/C19H17Cl2N3O5S.Na.H2O/c1-7-10(12(23-29-7)11-8(20)5-4-6-9(11)21)15(25)22-13-16(26)24-14(18(27)28)19(2,3)30-17(13)24;;/h4-6,13-14,17H,1-3H3,(H,22,25)(H,27,28);;1H2/q;+1;/p-1/t13-,14+,17-;;/m1../s1

Molecular Formula

C19H16Cl2N3NaO5S

HBD / HBA

1 / 7

Ikatan yang Dapat Dirotasi

4

Atom Berat

31

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

The sodium salt form of dicloxacillin, a beta-lactamase-stable penicillin antibiotic used for skin infections and other conditions caused by beta-lactamase-producing staphylococci. It is taken by mouth and well tolerated.

Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), preventing transpeptidation and cross-linking of peptidoglycan chains. This weakens the bacterial cell wall, leading to osmotic lysis and cell death.

Yes, Dicloxacillin Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200701. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 23667628. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Mencari informasi yang ramah bagi pasien?

Dicloxacillin Sodium di PillFYI

Struktur

Data Cepat

Rumus: C19H16Cl2N3NaO5S

Tautan Eksternal

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.